Cigna Group (NYSE:CI) stock trades higher as the company raises its 2025 earnings outlook after better than expected Q1 2025 ...

The federal judge overseeing nationwide litigation over the opioid crisis has denied pharmacy benefit managers OptumRx and ...

The state of Michigan has sued pharmacy benefit managers Express Scripts and Prime Therapeutics for anticompetitive behavior ...

An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

Biocon Biologics Ltd., today announced the Company has secured multiple market access agreements for Yesintek™ ...

Biocon Biologics (BBL), subsidiary of Biocon, today announced the Company has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab). The ...

In a lawsuit against St. Louis-based Express Scripts and Eagan, Minn,-based Prime Therapeutics in U.S. District Court in ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

Michigan Attorney General Dana Nessel sued Express Scripts Inc. and Prime Therapeutics LLC, two pharmacy benefit managers ...

Biocon advanced 3.17% to Rs 328.75 after Biocon Biologics (BBL) secures multiple market access agreements in the United States for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab), ...